The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/77009DF4.svg?ark=w1%2F20260515%2F77009DF4)](https://nobleid.org/work/w1/20260515/77009DF4)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors